F.L. Putnam Investment Management’s DexCom DXCM Stock Holding History

F.L. Putnam Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Buy	+15,705	New	+$1.05M	0.01%	361

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DCP

DSM Capital Partners Palm Beach Gardens, Florida $5.84B AUM 22.63% 1-Year Est. Return

F.L. Putnam Investment Management's DXCM Position: Q2 2026 in Review

F.L. Putnam Investment Management opened a new position in DexCom (DXCM) in Q2 2026: 15,705 shares worth $1.06M. The stake represents 0.01% of the portfolio and ranks #361 among its holdings.

553 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

F.L. Putnam Investment Management held 15,705 shares of DexCom worth $1.06M as of Q2 2026.
DexCom was a new F.L. Putnam Investment Management position in Q2 2026.
DexCom made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #361 holding.
553 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.